INNOSCIENCE (02577) Income Statement & Earnings

76.800
-9.400-10.90%

Market Closed May 15 16:08 CST

70.28BMarket Cap-75.52P/E (TTM)

INNOSCIENCE (02577) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Turnover

46.45%1.21B

43.43%553.35M

39.77%828.46M

25.22%385.81M

335.26%592.72M

--308.11M

99.62%136.17M

--68.22M

Operating income

46.45%1.21B

43.43%553.35M

39.77%828.46M

25.22%385.81M

335.26%592.72M

308.11M

99.62%136.17M

68.22M

Cost of sales

-13.60%-1.12B

-9.90%-515.51M

-3.68%-989.88M

13.58%-469.05M

-80.05%-954.79M

---542.76M

-112.33%-530.28M

---249.75M

Operating expenses

-13.60%-1.12B

-9.90%-515.51M

-3.68%-989.88M

13.58%-469.05M

-80.05%-954.79M

-542.76M

-112.33%-530.28M

-249.75M

Gross profit

154.99%88.76M

145.47%37.85M

55.42%-161.42M

64.52%-83.24M

8.13%-362.07M

-234.64M

-117.10%-394.11M

-181.53M

Selling expenses

-12.32%-109.97M

-6.37%-53.88M

-8.67%-97.91M

-12.95%-50.65M

-29.98%-90.1M

---44.84M

-143.78%-69.32M

---28.43M

Administrative expenses

-4.26%-470.4M

-21.53%-245.51M

-82.61%-451.16M

-127.18%-202.02M

-24.01%-247.07M

---88.92M

-11.24%-199.23M

---179.1M

Research and development expenses

-15.85%-374.24M

-11.60%-162.33M

7.38%-323.03M

13.36%-145.45M

39.98%-348.75M

---167.88M

12.18%-581.09M

---661.7M

Special items of operating profit

56.58%113.1M

27.41%47.97M

11.19%72.23M

93.98%37.65M

-4.41%64.96M

--19.41M

56.03%67.96M

--43.56M

Operating profit

21.69%-752.74M

15.28%-375.9M

2.21%-961.28M

14.16%-443.71M

16.39%-983.02M

-516.88M

-16.74%-1.18B

-1.01B

Financing cost

-3.80%-87.26M

-19.00%-52.51M

29.30%-84.07M

29.75%-44.12M

88.45%-118.91M

---62.81M

56.96%-1.03B

---2.39B

Earning before tax

19.64%-840M

12.18%-428.41M

5.14%-1.05B

15.85%-487.83M

50.04%-1.1B

-579.7M

35.12%-2.21B

-3.4B

Tax

-53.43%-514K

-57.40%-266K

-2,292.86%-335K

---169K

79.10%-14K

----

---67K

----

After-tax profit from continuing operations

19.62%-840.51M

12.16%-428.67M

5.11%-1.05B

15.82%-488M

50.04%-1.1B

-579.7M

35.12%-2.21B

-3.4B

Earning after tax

19.62%-840.51M

12.16%-428.67M

5.11%-1.05B

15.82%-488M

50.04%-1.1B

-579.7M

35.12%-2.21B

-3.4B

Profit attributable to shareholders

19.62%-840.51M

12.16%-428.67M

5.11%-1.05B

15.82%-488M

50.04%-1.1B

-579.7M

35.12%-2.21B

-3.4B

Basic earnings per share

25.78%-0.95

18.33%-0.49

7.25%-1.28

-0.6

-1.38

Diluted earnings per share

25.78%-0.95

18.33%-0.49

7.25%-1.28

-0.6

-1.38

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Turnover	46.45%1.21B	43.43%553.35M	39.77%828.46M	25.22%385.81M	335.26%592.72M	--308.11M	99.62%136.17M	--68.22M
Operating income	46.45%1.21B	43.43%553.35M	39.77%828.46M	25.22%385.81M	335.26%592.72M	308.11M	99.62%136.17M	68.22M
Cost of sales	-13.60%-1.12B	-9.90%-515.51M	-3.68%-989.88M	13.58%-469.05M	-80.05%-954.79M	---542.76M	-112.33%-530.28M	---249.75M
Operating expenses	-13.60%-1.12B	-9.90%-515.51M	-3.68%-989.88M	13.58%-469.05M	-80.05%-954.79M	-542.76M	-112.33%-530.28M	-249.75M
Gross profit	154.99%88.76M	145.47%37.85M	55.42%-161.42M	64.52%-83.24M	8.13%-362.07M	-234.64M	-117.10%-394.11M	-181.53M
Selling expenses	-12.32%-109.97M	-6.37%-53.88M	-8.67%-97.91M	-12.95%-50.65M	-29.98%-90.1M	---44.84M	-143.78%-69.32M	---28.43M
Administrative expenses	-4.26%-470.4M	-21.53%-245.51M	-82.61%-451.16M	-127.18%-202.02M	-24.01%-247.07M	---88.92M	-11.24%-199.23M	---179.1M
Research and development expenses	-15.85%-374.24M	-11.60%-162.33M	7.38%-323.03M	13.36%-145.45M	39.98%-348.75M	---167.88M	12.18%-581.09M	---661.7M
Special items of operating profit	56.58%113.1M	27.41%47.97M	11.19%72.23M	93.98%37.65M	-4.41%64.96M	--19.41M	56.03%67.96M	--43.56M
Operating profit	21.69%-752.74M	15.28%-375.9M	2.21%-961.28M	14.16%-443.71M	16.39%-983.02M	-516.88M	-16.74%-1.18B	-1.01B
Financing cost	-3.80%-87.26M	-19.00%-52.51M	29.30%-84.07M	29.75%-44.12M	88.45%-118.91M	---62.81M	56.96%-1.03B	---2.39B
Earning before tax	19.64%-840M	12.18%-428.41M	5.14%-1.05B	15.85%-487.83M	50.04%-1.1B	-579.7M	35.12%-2.21B	-3.4B
Tax	-53.43%-514K	-57.40%-266K	-2,292.86%-335K	---169K	79.10%-14K	----	---67K	----
After-tax profit from continuing operations	19.62%-840.51M	12.16%-428.67M	5.11%-1.05B	15.82%-488M	50.04%-1.1B	-579.7M	35.12%-2.21B	-3.4B
Earning after tax	19.62%-840.51M	12.16%-428.67M	5.11%-1.05B	15.82%-488M	50.04%-1.1B	-579.7M	35.12%-2.21B	-3.4B
Profit attributable to shareholders	19.62%-840.51M	12.16%-428.67M	5.11%-1.05B	15.82%-488M	50.04%-1.1B	-579.7M	35.12%-2.21B	-3.4B
Basic earnings per share	25.78%-0.95	18.33%-0.49	7.25%-1.28	-0.6	-1.38
Diluted earnings per share	25.78%-0.95	18.33%-0.49	7.25%-1.28	-0.6	-1.38
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	KPMG	--	KPMG	--	KPMG	--	KPMG	KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"